Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 5/20 | 0.64 |
| ▸ | DRD4 | P21917 | 1/20 | 0.64 |
| ▸ | DRD1 | P21728 | 3/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16625803 | 0.85 | MTNR1B (0.47) | DRD2DRD4DRD1KCNH2MAPK1 | |
| SCHEMBL16625811 | 0.84 | DRD2 (0.45) | DRD2DRD4DRD1KCNH2 | |
| SCHEMBL16625795 | 0.83 | DRD2 (0.45) | DRD2DRD4DRD1KCNH2LMNA | |
| SCHEMBL16625800 | 0.80 | GRIN2C (0.46) | DRD2DRD4LMNA | |
| SCHEMBL29617590 | 0.78 | DRD2 (1.00) | DRD2DRD4DRD1KCNH2KDM4E | |
| SCHEMBL13356020 | 0.78 | DRD2 (1.00) | DRD2DRD4DRD1KCNH2KDM4E | |
| SCHEMBL12588843 | 0.78 | DRD2 (0.64) | DRD2DRD4DRD1KCNH2KDM4E | |
| SCHEMBL8741257 | 0.77 | PARP1 (0.61) | DRD2DRD4DRD1KDM4EHSD17B10 | |
| SCHEMBL14848646 | 0.76 | DRD2 (0.76) | DRD2DRD4DRD1KCNH2KDM4E | |
| SCHEMBL16772352 | 0.75 | DRD2 (0.74) | DRD2DRD4DRD1KCNH2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921561-B2 | One-pot preparation of hexahydroisoquinolines from amides | MALLINCKRODT LLC (US) | 2014-12-30 | — | — | US | disclosed |
| US-20130137874-A1 | One-Pot Preparation of Hexahydroisoquinolines from Amides | MALLINCKRODT LLC (US) | 2013-05-30 | — | — | US | disclosed |
| US-8431705-B2 | One-pot preparation of hexahydroisoquinolines from amides | MALLINCKRODT LLC (US) | 2013-04-30 | — | — | US | disclosed |
| US-20110071299-A1 | One-Pot Preparation of Hexahydroisoquinolines from Amides | MALLINCKRODT INC. (US) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071299-A1 | One-Pot Preparation of Hexahydroisoquinolines from Amides | QARS1, QTRT1, SFPQ | DRD2 2265/4885DRD4 1515/4885DRD1 1301/4885 |
| US-20130137874-A1 | One-Pot Preparation of Hexahydroisoquinolines from Amides | QARS1, QTRT1, SFPQ | DRD2 2265/4885DRD4 1515/4885DRD1 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.